Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy.
Micantonio
Tamara
T
Fargnoli
Maria Concetta
MC
Ricevuto
Enrico
E
Ficorella
Corrado
C
Marchetti
Paolo
P
Peris
Ketty
K
D017486:Acneiform Eruptions / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068818:Cetuximab; D003875:Drug Eruptions / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013754:Tetracyclines / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D013754:Tetracyclines; D000068818:Cetuximab